Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1989 1
1993 2
1994 1
1995 2
1997 1
1999 2
2001 3
2002 3
2006 2
2009 7
2010 6
2011 4
2012 1
2013 2
2014 3
2015 3
2016 5
2017 4
2018 4
2019 5
2020 3
2021 12
2022 7
2023 3
2024 2
2025 3
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Intrathecal Gene Therapy for Giant Axonal Neuropathy.
Bharucha-Goebel DX, Todd JJ, Saade D, Norato G, Jain M, Lehky T, Bailey RM, Chichester JA, Calcedo R, Armao D, Foley AR, Mohassel P, Tesfaye E, Carlin BP, Seremula B, Waite M, Zein WM, Huryn LA, Crawford TO, Sumner CJ, Hoke A, Heiss JD, Charnas L, Hooper JE, Bouldin TW, Kang EM, Rybin D, Gray SJ, Bönnemann CG; GAN Trial Team. Bharucha-Goebel DX, et al. N Engl J Med. 2024 Mar 21;390(12):1092-1104. doi: 10.1056/NEJMoa2307952. N Engl J Med. 2024. PMID: 38507752 Free PMC article.
The key secondary clinical end point was at least a 95% posterior probability of slowing the rate of change (i.e., slope) in the 32-item Motor Function Measure total percent score at 1 year after treatment, as compared with the pretreatment slope. ...
The key secondary clinical end point was at least a 95% posterior probability of slowing the rate of change (i.e., slope) in the 32-i …
Pulmonary Dysfunction after Pediatric COVID-19.
Heiss R, Tan L, Schmidt S, Regensburger AP, Ewert F, Mammadova D, Buehler A, Vogel-Claussen J, Voskrebenzev A, Rauh M, Rompel O, Nagel AM, Lévy S, Bickelhaupt S, May MS, Uder M, Metzler M, Trollmann R, Woelfle J, Wagner AL, Knieling F. Heiss R, et al. Radiology. 2023 Mar;306(3):e221250. doi: 10.1148/radiol.221250. Epub 2022 Sep 20. Radiology. 2023. PMID: 36125379 Free PMC article. Clinical Trial.
Stroke--acute interventions.
Heiss WD. Heiss WD. J Neural Transm Suppl. 2002;(63):37-57. doi: 10.1007/978-3-7091-6137-1_3. J Neural Transm Suppl. 2002. PMID: 12597608 Review.
That this is the case can be seen from the results of many controlled therapeutic trials, in which up to now only thrombolytic therapy with a 3 h time window for systemic and a 6 h time window for intraarterial application proved its efficacy, whereas all trials wit …
That this is the case can be seen from the results of many controlled therapeutic trials, in which up to now only thrombolytic therapy with …
Stroke: working toward a prioritized world agenda.
Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, Rothwell PM, Sacco RL, Smith SC Jr, Wang Y, Bryer A, Ford GA, Iadecola C, Martins SC, Saver J, Skvortsova V, Bayley M, Bednar MM, Duncan P, Enney L, Finklestein S, Jones TA, Kalra L, Kleim J, Nitkin R, Teasell R, Weiller C, Desai B, Goldberg MP, Heiss WD, Saarelma O, Schwamm LH, Shinohara Y, Trivedi B, Wahlgren N, Wong LK, Hakim A, Norrving B, Prudhomme S, Bornstein NM, Davis SM, Goldstein LB, Leys D, Tuomilehto J. Hachinski V, et al. Int J Stroke. 2010 Aug;5(4):238-56. doi: 10.1111/j.1747-4949.2010.00442.x. Int J Stroke. 2010. PMID: 20636706 Free PMC article.
Prospects of nanoscience with nanocrystals.
Kovalenko MV, Manna L, Cabot A, Hens Z, Talapin DV, Kagan CR, Klimov VI, Rogach AL, Reiss P, Milliron DJ, Guyot-Sionnnest P, Konstantatos G, Parak WJ, Hyeon T, Korgel BA, Murray CB, Heiss W. Kovalenko MV, et al. ACS Nano. 2015 Feb 24;9(2):1012-57. doi: 10.1021/nn506223h. Epub 2015 Jan 22. ACS Nano. 2015. PMID: 25608730 Review.
Colloidal nanocrystals (NCs, i.e., crystalline nanoparticles) have become an important class of materials with great potential for applications ranging from medicine to electronic and optoelectronic devices. ...
Colloidal nanocrystals (NCs, i.e., crystalline nanoparticles) have become an important class of materials with great potential for ap …
A short history of neurosciences in Austria.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2006 Mar;113(3):271-82. doi: 10.1007/s00702-005-0400-7. J Neural Transm (Vienna). 2006. PMID: 16453085
Pollak (Wilson disease), E. Gamper (mesencephalic subject), J. Gerstmann (Gerstmann-Straussler-Scheinker syndrome and Gerstmann parietal syndrome), H. ...Reisner,W. Birkmayer, H. Petsche, F. Gerstenbrand, H. Bernheimer, H. W. Heiss, H …
Pollak (Wilson disease), E. Gamper (mesencephalic subject), J. Gerstmann (Gerstmann-Straussler-Scheinker syndrome and Gerstmann parie …
GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes.
Franceschini N, Giambartolomei C, de Vries PS, Finan C, Bis JC, Huntley RP, Lovering RC, Tajuddin SM, Winkler TW, Graff M, Kavousi M, Dale C, Smith AV, Hofer E, van Leeuwen EM, Nolte IM, Lu L, Scholz M, Sargurupremraj M, Pitkänen N, Franzén O, Joshi PK, Noordam R, Marioni RE, Hwang SJ, Musani SK, Schminke U, Palmas W, Isaacs A, Correa A, Zonderman AB, Hofman A, Teumer A, Cox AJ, Uitterlinden AG, Wong A, Smit AJ, Newman AB, Britton A, Ruusalepp A, Sennblad B, Hedblad B, Pasaniuc B, Penninx BW, Langefeld CD, Wassel CL, Tzourio C, Fava C, Baldassarre D, O'Leary DH, Teupser D, Kuh D, Tremoli E, Mannarino E, Grossi E, Boerwinkle E, Schadt EE, Ingelsson E, Veglia F, Rivadeneira F, Beutner F, Chauhan G, Heiss G, Snieder H, Campbell H, Völzke H, Markus HS, Deary IJ, Jukema JW, de Graaf J, Price J, Pott J, Hopewell JC, Liang J, Thiery J, Engmann J, Gertow K, Rice K, Taylor KD, Dhana K, Kiemeney LALM, Lind L, Raffield LM, Launer LJ, Holdt LM, Dörr M, Dichgans M, Traylor M, Sitzer M, Kumari M, Kivimaki M, Nalls MA, Melander O, Raitakari O, Franco OH, Rueda-Ochoa OL, Roussos P, Whincup PH, Amouyel P, Giral P, Anugu P, Wong Q, Malik R, Rauramaa R, Burkhardt R, Hardy R, Schmidt R, de Mutsert R,… See abstract for full author list ➔ Franceschini N, et al. Nat Commun. 2018 Dec 3;9(1):5141. doi: 10.1038/s41467-018-07340-5. Nat Commun. 2018. PMID: 30510157 Free PMC article.
Acidocalcisomes: Ultrastructure, Biogenesis, and Distribution in Microbial Eukaryotes.
Goodenough U, Heiss AA, Roth R, Rusch J, Lee JH. Goodenough U, et al. Protist. 2019 Jul;170(3):287-313. doi: 10.1016/j.protis.2019.05.001. Epub 2019 May 9. Protist. 2019. PMID: 31154072
They carry a transmembrane polyphosphate polymerase and two classes of proton pumps: H(+)-pyrophosphatases (H(+)-PPases) and V-type ATPases. This report describes acidocalcisomes that were snap-frozen in living cells, primarily the green alga Chlamydomonas reinhardt …
They carry a transmembrane polyphosphate polymerase and two classes of proton pumps: H(+)-pyrophosphatases (H(+)-PPases) and V …
Imaging in cerebrovascular disease.
Heiss WD, Forsting M, Diener HC. Heiss WD, et al. Curr Opin Neurol. 2001 Feb;14(1):67-75. doi: 10.1097/00019052-200102000-00011. Curr Opin Neurol. 2001. PMID: 11176220 Review.
Various functional imaging modalities can be applied in acute ischaemic stroke to identify functionally impaired, but morphologically preserved tissue (i.e. the penumbra), and to distinguish it from irreversibly damaged tissue. Flow thresholds for irreversible tissue destr …
Various functional imaging modalities can be applied in acute ischaemic stroke to identify functionally impaired, but morphologically preser …
82 results